Latest filing published 06 Nov 2018 for NYMOX PHARMACEUTICAL CORP, €154k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Paul Averback: trading record in brief
All filings by Paul Averback on record concern Nymox Pharmaceutical Corp. Between 26 October 2018 and 29 October 2018, the trades on record add up to 2 filings.
The open-market record consists of 2 sales worth €3.9M, with no purchase.
The newest entry dates from 6 November 2018: an open-market sale of €154k, in Nymox Pharmaceutical Corp. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paul Averback
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ US$1.75Restricted CommonSEC:0001569706-18-000003:0
- 1,687,600 shares@ US$2.50Restricted commonSEC:0001569706-18-000002:0
2 of 2 declarations